Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study

  • Sayaka Tsuda (作成者)
  • Azusa Sameshima (作成者)
  • Michikazu Sekine (寄稿者)
  • Haruna Kawaguchi (作成者)
  • Daisuke Fujita (作成者)
  • Shintaro Makino (作成者)
  • Akio Morinobu (作成者)
  • Yohko Murakawa (作成者)
  • Kiyoshi Matsui (作成者)
  • Takao Sugiyama (作成者)
  • Mamoru Watanabe (作成者)
  • Yasuo Suzuki (作成者)
  • Masakazu Nagahori (作成者)
  • Atsuko Murashima (作成者)
  • Tatsuya Atsumi (作成者)
  • Kenji Oku (作成者)
  • Nobuaki Mitsuda (作成者)
  • Syuji Takei (寄稿者)
  • Takako Miyamae (作成者)
  • Naoto Takahashi (作成者)
  • Ken Nakajima (作成者)
  • Shigeru Saito (作成者)

データセット

説明

Objective: To describe the pre-conception status, pregnancy outcomes, and medication prevalence in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Crohn’s disease (CD), and ulcerative colitis (UC). Methods: E-mail-based questionnaire survey for the Japan Maternal Fetal Intensive Care Unit Network hospitals inquiring prevalence and clinical features of SLE, RA, CD and UC complicated pregnancies for 2 years. Results: The number of SLE, RA, CD and UC among 69,810 deliveries was 184, 139, 27 and 178, respectively. Less than half of pregnancies were planned. Assisted reproductive technology (ART) pregnancy rates were higher in SLE, RA and UC than in the general population (11.4, 23.0 and 7.4 vs 5.1%, p p p p p p p Conclusion: SLE, RA, CD, and UC complicated pregnancies were at high risks of obstetric adverse outcome. High ART rates necessitate pre-conception counseling in SLE, RA, and UC pregnancies.
利用可能になった日2019
出版社Taylor & Francis

引用スタイル